GRIN Grown Rogue International Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · grownrogue.com

0.5500CAD-6.78%Mkt Cap: 100.11M $P/E: —3d ago

Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flowe…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap100.11M USD

Enterprise Value116.34M USD

Revenue (TTM)27.45M USD

Gross Profit10.30M USD

Net Income (TTM)1.26M USD

Revenue/Share0.15 CAD

Last Price0.5500 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA126.09

EV/Revenue4.24

P/S3.65

P/B6.33

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.380050% of range0.7200

52W High0.7200 CAD

52W Low0.3800 CAD

Profitability

Gross Margin43.62%

Oper. Margin7.42%

EBITDA Margin3.36%

Profit Margin5.33%

ROE8.28%

ROA2.76%

Growth

Revenue Growth40.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF2.60M USD

CapEx (TTM)3.39M USD

FCF Margin-4.70%

FCF Yield-1.29%

Net Debt11.52M USD

Net Debt/EBITDA12.49

Balance Sheet

Debt/Equity1.28

Current Ratio2.59

Quick Ratio1.75

Book Value/Sh0.09 CAD

Cash/Share0.05 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:1.4

Split DateNov 26, 2018

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.249.94M

Float153.67M

Insiders29.60%

Institutions8.61%

Short Interest

Short Ratio2.2d

Short % Float0.03%

Short % Out.0.02%

Shares Short57.06K

Short (prev mo.)106.95K

Technical

SMA 500.6052 (-9.1%)

SMA 2000.5513 (-0.2%)

Beta-1.03

S&P 52W Chg14.58%

Avg Vol (30d)34.36K

Avg Vol (10d)44.53K

Technical Indicators

RSI (14)43.2

MACD-0.0025

MACD Signal-0.0021

MACD Hist.-0.0004

BB Upper0.6496 CAD

BB Middle0.5810 CAD

BB Lower0.5124 CAD

BB Width23.63%

ATR (14)0.0416 CAD

Vol Ratio (20d)0.87x